{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T16:27:34Z","timestamp":1697041654780},"reference-count":10,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1517\/13543784.8.2.173","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T18:24:35Z","timestamp":1115231075000},"page":"173-180","source":"Crossref","is-referenced-by-count":4,"title":["S 18326: a thrombin inhibitor that shows potential for oral treatment of thromboembolic disorders"],"prefix":"10.1517","volume":"8","author":[{"given":"Guillaume","family":"De Nanteuil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony J","family":"Verbeuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1997.022.08.425700"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199711063371901"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3011.1978.tb02889.x"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(91)90073-X"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0038-1642724","volume":"74","author":"CALLAS D","year":"1995","journal-title":"Implication in drug development. Thrombosis Haemostasis"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(00)60190-9"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1055\/s-0038-1657718","volume":"78","author":"RUPIN A","year":"1997","journal-title":"Thrombosis Haemostasis"},{"key":"CIT0012","first-page":"1309","volume":"73","author":"RUPIN A","year":"1995","journal-title":"Thrombosis Haemostasis"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1021\/om50005a008"},{"key":"CIT0016","first-page":"1310","volume":"73","author":"VERBEUREN TJ","year":"1995","journal-title":"A potent orally active tripeptide boronic acid thrombin inhibitor. Thrombosis Haemostasis"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.8.2.173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T06:34:24Z","timestamp":1586241264000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.8.2.173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,2,23]]},"published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1517\/13543784.8.2.173"],"URL":"https:\/\/doi.org\/10.1517\/13543784.8.2.173","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]}}}